NDAORALSUSPENSION, EXTENDED RELEASE
Approved
Oct 2015
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Data completeness
6/8 — Strong
DYANAVEL XR (amphetamine) by Teva is non-catecholamine sympathomimetic amines with cns stimulant activity. First approved in 2015.
Drug data last refreshed 12h ago · AI intelligence enriched 14h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DYANAVEL XR is an extended-release oral suspension formulation of amphetamine, a CNS stimulant indicated for ADHD. It works as a non-catecholamine sympathomimetic amine, though the exact mechanism in ADHD remains not fully understood. The liquid suspension format offers flexible dosing and is designed for extended therapeutic coverage.
$0.483MPart D
PeakStable
10.0 years to LOEProduct is in peak commercial phase with modest Part D utilization; limited team expansion expected but role stability is high in this mature ADHD stimulant market.
Mechanism of Action
non-catecholamine sympathomimetic amines with CNS stimulant activity. The mode of therapeutic action in ADHD is not known.
Pharmacologic Class:
Central Nervous System Stimulant
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Methamphetamine Use Disorder Support in Heart Failure Pilot Study
Started May 2026
50 enrolled
Heart FailureMethamphetamine Use Disorder
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
Started Feb 2026
40 enrolled
Methamphetamine IntoxicationMethamphetamine DisordersMethamphetamine Abuse
Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD)
Started Feb 2026
35 enrolled
Methamphetamine Abuse
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
Started Sep 2024
20 enrolled
Methamphetamine Use Disorder
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
Started Aug 2024
200 enrolled
Methamphetamine UseHeart Failure
Worked on DYANAVEL XR at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.